CogniFlow
en
en
en
en
en
en
en
en
en
Date of Foundation
21.08.2025

CogniFlow

"Revolutionizing Biotech with Smart, Energy-Efficient Modularity"

Contact

The Idea origin story

CogniFlow transforms droplet microfluidic automation, making it accessible for labs everywhere. By leveraging our unique combination of modular hardware, cutting-edge AI, and energy-efficient design, we empower researchers and SMEs to automate biomanufacturing processes like cell factory design and enzyme/antibody screening. This holistic approach greatly reduces costs and complexities. Creating a vital connection between electronics and biology, CogniFlow fuels discovery by providing smart, scalable, and cost-effective droplet biotechnology.

The Mission

We create intelligent platforms that automate and optimize cell factories for SMEs and researchers, bridging electronics and biology affordably.

Clients

Our customers are biotech SMEs, startups and researchers in food and biomedical sectors seeking affordable droplet automation to scale cell design workflows.

Problems we solve

Client’s problem

Confirmation of problem

The actuality of the problem is confirmed by the fact that labs and SMEs struggle to affordably scale bio-manufacturing processes.

Solution

CogniFlow DropletFactory revolutionizes bio-manufacturing with rapid, energy-efficient cell factory design. It's highly portable, affordable, and seamlessly integrates with lab workflows.

Our technologies

This solution is based on technologies

How it works

Our technology encapsulates cells into micro droplets. Using edge-AI, we sort and select optimal variants at high speed.

Value for the client

With CogniFlow's automation, customers save time and cost, accelerating research and the commercialization of biomanufacturing processes.

Market and strategy

Market size

94.5

mln/year

We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal

3

% of the market

Is our goal in the next 3 years

Team

My name’s

Tamás Pardy

My key role in the product

As CEO and lead architect of CogniFlow, I have 10+ years experience in medical devices. Besides business development, I oversee team growth and ensure regulatory compliance.

Team size and key members

My team is composed of experienced professionals: Rauno, our engineering lead; Simona, who handles biotech R&D and client relations; and Ott, responsible for sales.

Competitors

Competitors

PitchBob’s recommendation: We primarily compete with On-Chip Biotechnologies, Atrandi, Livedrop-Bio, and Sphere Bio in droplet-assisted automation. However, our platform outperforms them on flexibility, energy-efficiency and cost-effectiveness. Additionally, we surpass pipetting robot makers like Opentrons and Hamilton Robotics on throughput and price point.

Our Advantages

Our CogniFlow DropletFactory uniquely combines modular hardware and AI within a compact, portable box. It offers affordability with 2-5x lower cost and 5-10x lesser energy usage than competitors. This empowers biotech teams to accelerate cell factory commercialization seamlessly.

Business model

Our primary revenue streams are workflow customization services, instrument sales, consumables sales, and maintenance/upgrades.

Traction

In the past six months, we've secured our first customer for a paid pilot study, spun off from our university with an IP agreement and entered Health Founders Estonia 2025. We also garnered interest from additional customers in Estonia and Latvia, validating our platform's value proposition.

We aim to achieve competitive performance metrics, validate our platform with three customer site pilots, secure leads and distributor contacts, solidify our IP rights including sorting platform model, expand our team for scalability and refine a customer-validated business plan.

Metrics

We monitor key metrics like prototype performance, usability, user base and cost. Our droplet generation now performs at 1500Hz with uniform size at 7W power draw. Edge-AI detection improves cell classification to 99.5% accuracy at lower power consumption ensuring increased usability and maintaining costs.

We formally started our operations in August 2025 and we've since secured our first sale at €31k. Besides that, over the last five years as an academic project, we have effectively raised more than €2.5 million through EU and national grants.

Incorporation

Our company incorporated in

Tallinn, Estonia

Key risks

Our primary risks involve potential slow market adoption owing to limited droplet technology awareness or scaling-up challenges. Funding issues might reduce our scaling speed. Existing competitors may pivot towards low-end solutions, although their current focus remains on high-end markets.

Investments

$

2500000

We raised investments

Our Investors

We're self-funded via EU and Estonian grants, operating within Tallinn University of Technology. We spun off recently licensing our IP for 8% equity.

Rising Investments

$

500000

Currently, we are raising investments

$

4500000

Estimated pre-investment valuation of the company

Request additional information

We’re looking for a co-founders

Open positions

Article

Read

Additional information

CogniFlow makes droplet microfluidics accessible to every lab. Our modular, low-power instruments automate cell factory design and screening, helping biotech SMEs and researchers accelerate innovation at a fraction of current cost and complexity.

CogniFlow
MVP
Date of Foundation
21.08.2025